Oxyglobin: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 1: | Line 1: | ||
{{WikiDoc Cardiology News}} | {{WikiDoc Cardiology News}} | ||
{{CMG}} | {{CMG}} | ||
Latest revision as of 20:30, 4 September 2012
Template:WikiDoc Cardiology News Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Similar to Hemopure, Oxyglobin is also developed by Biopure and is an oxygen-therapeutic based on chemically stabilized bovine hemoglobin. However, unlike Hemopure, which is for human use, Oxyglobin is intended for the veterinary market, and is used to treat anemia in dogs. According to Biopure's corporate website, approximately 173,000 units of Oxyglobin have been sold to date, treating nearly 90,000 animals.